Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Dec. 31, 2022   65,739,053      
Beginning balance at Dec. 31, 2022 $ 83,219 $ 0 $ 314,884 $ (231,636) $ (29)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares from stock option exercises (in shares)   350,141      
Issuance of common shares from stock option exercises 621   621    
Issuance of common shares from the employee stock purchase plan (in shares)   134,336      
Issuance of common shares from the employee stock purchase plan $ 622   622    
Vesting of restricted stock units (in shares)   1,633,066      
Common stock withheld related to net settlement of equity awards (in shares) (533,513) (533,513)      
Common stock withheld related to net settlement of equity awards $ (2,672)   (2,672)    
Stock-based compensation 10,389   10,389    
Foreign currency translation adjustments, net of tax 112       112
Net unrealized loss on investments (52)       (52)
Net loss (16,847)     (16,847)  
Ending balance (in shares) at Jun. 30, 2023   67,323,083      
Ending balance at Jun. 30, 2023 75,392 $ 0 323,844 (248,483) 31
Beginning balance (in shares) at Mar. 31, 2023   66,337,452      
Beginning balance at Mar. 31, 2023 79,799 $ 0 319,339 (239,495) (45)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares from stock option exercises (in shares)   308,966      
Issuance of common shares from stock option exercises $ 548   548    
Vesting of restricted stock units (in shares)   1,046,426      
Common stock withheld related to net settlement of equity awards (in shares) (369,761) (369,761)      
Common stock withheld related to net settlement of equity awards $ (1,919)   (1,919)    
Stock-based compensation 5,876   5,876    
Foreign currency translation adjustments, net of tax 146       146
Net unrealized loss on investments (70)       (70)
Net loss (8,988)     (8,988)  
Ending balance (in shares) at Jun. 30, 2023   67,323,083      
Ending balance at Jun. 30, 2023 $ 75,392 $ 0 323,844 (248,483) 31
Beginning balance (in shares) at Dec. 31, 2023 70,116,357 70,116,357      
Beginning balance at Dec. 31, 2023 $ 78,957 $ 0 341,514 (262,667) 110
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares from stock option exercises (in shares) 60,548        
Ending balance (in shares) at Mar. 31, 2024   70,980,371      
Ending balance at Mar. 31, 2024 $ 73,436 $ 0 343,496 (269,870) (190)
Beginning balance (in shares) at Dec. 31, 2023 70,116,357 70,116,357      
Beginning balance at Dec. 31, 2023 $ 78,957 $ 0 341,514 (262,667) 110
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares from stock option exercises (in shares)   92,893      
Issuance of common shares from stock option exercises 357   357    
Issuance of common shares from the employee stock purchase plan (in shares)   113,959      
Issuance of common shares from the employee stock purchase plan $ 1,020   1,020    
Vesting of restricted stock units (in shares)   2,220,075      
Common stock withheld related to net settlement of equity awards (in shares) (861,017) (861,017)      
Common stock withheld related to net settlement of equity awards $ (9,422)   (9,422)    
Stock-based compensation 15,063   15,063    
Foreign currency translation adjustments, net of tax (309)       (309)
Net unrealized loss on investments (87)       (87)
Net loss $ (15,756)     (15,756)  
Ending balance (in shares) at Jun. 30, 2024 71,682,267 71,682,267      
Ending balance at Jun. 30, 2024 $ 69,823 $ 0 348,532 (278,423) (286)
Beginning balance (in shares) at Mar. 31, 2024   70,980,371      
Beginning balance at Mar. 31, 2024 $ 73,436 $ 0 343,496 (269,870) (190)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares from stock option exercises (in shares) 32,345 32,345      
Issuance of common shares from stock option exercises $ 66   66    
Vesting of restricted stock units (in shares)   1,014,237      
Common stock withheld related to net settlement of equity awards (in shares) (344,686) (344,686)      
Common stock withheld related to net settlement of equity awards $ (3,321)   (3,321)    
Stock-based compensation 8,291   8,291    
Foreign currency translation adjustments, net of tax (71)       (71)
Net unrealized loss on investments (25)       (25)
Net loss $ (8,553)     (8,553)  
Ending balance (in shares) at Jun. 30, 2024 71,682,267 71,682,267      
Ending balance at Jun. 30, 2024 $ 69,823 $ 0 $ 348,532 $ (278,423) $ (286)